A Strong Case for Viral Genetic Factors in HIV Virulence

HIV infections show great variation in the rate of progression to disease, and the role of viral genetic factors in this variation had remained poorly characterized until recently. Now a series of four studies [1–4] published within a year has filled this important gap and has demonstrated a robust effect of the viral genotype on HIV virulence.

[1]  Ard van Sighem,et al.  Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands , 2009, PloS one.

[2]  Douglas D. Richman,et al.  Viral Dynamics of Acute HIV-1 Infection , 1999, The Journal of experimental medicine.

[3]  Lei Wang,et al.  A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. , 2006, The Journal of infectious diseases.

[4]  A. Sönnerborg,et al.  Kinetics of HIV-1 RNA and resistance-associated mutations after cessation of antiretroviral combination therapy , 2001, AIDS.

[5]  S. Harrison,et al.  Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature , 2022, Viruses.

[6]  B. Walker,et al.  Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703–positive individuals and their transmission recipients , 2009, The Journal of experimental medicine.

[7]  N. Mehra,et al.  Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes. , 2009, Tissue antigens.

[8]  Konrad Scheffler,et al.  Evidence of HIV-1 adaptation to host HLA alleles following chimp-to-human transmission , 2009, Virology Journal.

[9]  P. Massip,et al.  CXCR4-using viruses in plasma and peripheral blood mononuclear cells during primary HIV-1 infection and impact on disease progression , 2010, AIDS.

[10]  Philippe Froguel,et al.  Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). , 2009, The Journal of infectious diseases.

[11]  Marion Cornelissen,et al.  HIV RNA levels in transmission sources only weakly predict plasma viral load in recipients. , 2010, AIDS.

[12]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[13]  W. G. Hill,et al.  Heritability in the genomics era — concepts and misconceptions , 2008, Nature Reviews Genetics.

[14]  J. S. Sullivan,et al.  Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.

[15]  J. Goedert,et al.  Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS. , 2010, The Journal of infectious diseases.

[16]  J. Bull,et al.  Short-sighted evolution and the virulence of pathogenic microorganisms. , 1994, Trends in microbiology.

[17]  J. Margolick,et al.  Lack of Evidence for Changing Virulence of HIV-1 in North America , 2008, PloS one.

[18]  T. Klimkait,et al.  HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy , 2008, AIDS.

[19]  I. Thior,et al.  Human immunodeficiency virus type 1 subtypes differ in disease progression. , 1999, The Journal of infectious diseases.

[20]  Sebastian Bonhoeffer,et al.  Stable virulence levels in the HIV epidemic of Switzerland over two decades , 2006, AIDS.

[21]  I. Bartha,et al.  Has HIV evolved to induce immune pathogenesis? , 2008, Trends in immunology.

[22]  C. Moore,et al.  Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.

[23]  Samuel Alizon,et al.  The Evolutionary Dynamics of a Rapidly Mutating Virus within and between Hosts: The Case of Hepatitis C Virus , 2009, PLoS Comput. Biol..

[24]  B. Walker,et al.  Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[25]  W. Fawzi,et al.  Different rates of disease progression of HIV type 1 infection in Tanzania based on infecting subtype. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  D. Birx,et al.  Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus , 1995, Journal of virology.

[27]  M. Prins,et al.  Differences in CD4 Cell Counts at Seroconversion and Decline Among 5739 HIV-1–Infected Individuals with Well-Estimated Dates of Seroconversion , 2003, Journal of acquired immune deficiency syndromes.

[28]  Jeffrey N. Martin,et al.  In Vivo Fitness Cost of the M184V Mutation in Multidrug-Resistant Human Immunodeficiency Virus Type 1 in the Absence of Lamivudine , 2008, Journal of Virology.

[29]  Jianming Tang,et al.  HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners. , 2004, AIDS research and human retroviruses.

[30]  Jacques Fellay,et al.  A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.

[31]  A. Phillips,et al.  Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. , 2007, The Journal of infectious diseases.

[32]  A S Perelson,et al.  Modeling plasma virus concentration during primary HIV infection. , 2000, Journal of theoretical biology.

[33]  Alan S. Perelson,et al.  High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men , 2010, PLoS pathogens.

[34]  Martin A Nowak,et al.  Virus evolution within patients increases pathogenicity. , 2005, Journal of theoretical biology.

[35]  J. Kostman,et al.  Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection , 2009, Journal of acquired immune deficiency syndromes.

[36]  Scott Wegner,et al.  Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[37]  G. Rutherford,et al.  The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. , 1989, The New England journal of medicine.

[38]  D. Pillay,et al.  The effect of transmitted HIV-1 drug resistance on pre-therapy viral load , 2010, AIDS.

[39]  F. Hecht,et al.  The Relation Between Symptoms, Viral Load, and Viral Load Set Point in Primary HIV Infection , 2007, Journal of acquired immune deficiency syndromes.

[40]  Christl A. Donnelly,et al.  HIV-1 Transmitting Couples Have Similar Viral Load Set-Points in Rakai, Uganda , 2010, PLoS pathogens.

[41]  K. Crandall,et al.  The causes and consequences of HIV evolution , 2004, Nature Reviews Genetics.

[42]  Christophe Fraser,et al.  Interpretation of correlations in setpoint viral load in transmitting couples. , 2010, AIDS.

[43]  A. Telenti,et al.  Phylogenetic Approach Reveals That Virus Genotype Largely Determines HIV Set-Point Viral Load , 2010, PLoS pathogens.

[44]  T. Déirdre Hollingsworth,et al.  Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis , 2007, Proceedings of the National Academy of Sciences.

[45]  T. Garland,et al.  TESTING FOR PHYLOGENETIC SIGNAL IN COMPARATIVE DATA: BEHAVIORAL TRAITS ARE MORE LABILE , 2003, Evolution; international journal of organic evolution.

[46]  K. Shianna,et al.  Host determinants of HIV-1 control in African Americans. , 2010, The Journal of infectious diseases.

[47]  S. Lawn,et al.  Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection , 2001, Clinical Microbiology Reviews.

[48]  C. Petropoulos,et al.  Baseline HIV type 1 coreceptor tropism predicts disease progression. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  Athanasius F. M. Marée,et al.  Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[50]  O. Delaneau,et al.  Genomewide Association Study of a Rapid Progression Cohort Identifies New Susceptibility Alleles for Aids (anrs Genomewide Association Study 03) , 2022 .

[51]  G. Touloumi.  Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion , 2003 .

[52]  Carlo Torti,et al.  Increasing Clinical Virulence in Two Decades of the Italian HIV Epidemic , 2009, PLoS pathogens.

[53]  Sebastian Bonhoeffer,et al.  Viral Dynamics and In Vivo Fitness of HIV-1 in the Presence and Absence of Enfuvirtide , 2008, Journal of acquired immune deficiency syndromes.

[54]  Winston A Hide,et al.  Transmission of HIV-1 CTL Escape Variants Provides HLA-Mismatched Recipients with a Survival Advantage , 2008, PLoS pathogens.

[55]  Michael P Busch,et al.  Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection , 2003, AIDS.

[56]  D. Douek.  HIV disease progression: immune activation, microbes, and a leaky gut. , 2007, Topics in HIV medicine : a publication of the International AIDS Society, USA.

[57]  Hui Li,et al.  Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.

[58]  C. Rouzioux,et al.  No evidence of a change in HIV-1 virulence since 1996 in France , 2009, AIDS (London).

[59]  J. Kaldor,et al.  HIV infection in recipients of blood products from donors with known duration of infection , 1994, The Lancet.

[60]  Wendy Hartogensis,et al.  HIV RNA level in early infection is predicted by viral load in the transmission source , 2010, AIDS.

[61]  David Heckerman,et al.  Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients , 2008, The Journal of experimental medicine.

[62]  D Schenzle,et al.  A model for AIDS pathogenesis. , 1994, Statistics in medicine.

[63]  A. Perelson,et al.  Optimizing within-host viral fitness: infected cell lifespan and virion production rate. , 2004, Journal of theoretical biology.

[64]  M. Nowak,et al.  Specific therapy regimes could lead to long-term immunological control of HIV. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[65]  V. Jansen,et al.  The dual role of CD4 T helper cells in the infection dynamics of HIV and their importance for vaccination. , 2002, Journal of theoretical biology.

[66]  Sebastian Bonhoeffer,et al.  Glancing behind virus load variation in HIV-1 infection. , 2003, Trends in microbiology.

[67]  Z. Grossman,et al.  CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause? , 2002, Nature Medicine.

[68]  Oliver Laeyendecker,et al.  Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. , 2008, The Journal of infectious diseases.

[69]  Elizabeth T. Cirulli,et al.  Common Genetic Variation and the Control of HIV-1 in Humans , 2009, PLoS genetics.

[70]  S. Buchbinder,et al.  Long‐term HIV‐1 infection without immunologic progression , 1994, AIDS.